Mitsubishi UFJ Asset Management’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$254K Buy
27,092
+5,634
+26% +$52.8K ﹤0.01% 945
2025
Q1
$153K Buy
21,458
+4,165
+24% +$29.6K ﹤0.01% 987
2024
Q4
$210K Buy
17,293
+6,972
+68% +$84.6K ﹤0.01% 983
2024
Q3
$212K Sell
10,321
-966
-9% -$19.9K ﹤0.01% 957
2024
Q2
$253K Buy
11,287
+3,438
+44% +$76.9K ﹤0.01% 934
2024
Q1
$216K Sell
7,849
-355
-4% -$9.77K ﹤0.01% 956
2023
Q4
$242K Buy
8,204
+1,553
+23% +$45.8K ﹤0.01% 990
2023
Q3
$210K Buy
6,651
+451
+7% +$14.3K ﹤0.01% 1014
2023
Q2
$253K Buy
6,200
+647
+12% +$26.4K ﹤0.01% 1008
2023
Q1
$207K Buy
5,553
+401
+8% +$14.9K ﹤0.01% 1023
2022
Q4
$179K Sell
5,152
-130
-2% -$4.51K ﹤0.01% 1034
2022
Q3
$296K Buy
5,282
+286
+6% +$16K ﹤0.01% 977
2022
Q2
$259K Buy
4,996
+2,724
+120% +$141K ﹤0.01% 1014
2022
Q1
$165K Buy
2,272
+140
+7% +$10.2K ﹤0.01% 1082
2021
Q4
$254K Sell
2,132
-2,601
-55% -$310K ﹤0.01% 1042
2021
Q3
$635K Buy
4,733
+3
+0.1% +$402 ﹤0.01% 902
2021
Q2
$766K Sell
4,730
-5,670
-55% -$918K ﹤0.01% 892
2021
Q1
$835K Buy
10,400
+3,374
+48% +$271K 0.01% 817
2020
Q4
$382K Sell
7,026
-2,912
-29% -$158K ﹤0.01% 862
2020
Q3
$198K Buy
9,938
+121
+1% +$2.41K ﹤0.01% 898
2020
Q2
$206K Sell
9,817
-2,085
-18% -$43.8K ﹤0.01% 890
2020
Q1
$146K Buy
11,902
+2,392
+25% +$29.3K ﹤0.01% 890
2019
Q4
$139K Sell
9,510
-43
-0.5% -$628 ﹤0.01% 923
2019
Q3
$128K Buy
9,553
+1,859
+24% +$24.9K ﹤0.01% 878
2019
Q2
$126K Sell
7,694
-1,216
-14% -$19.9K ﹤0.01% 895
2019
Q1
$152K Buy
8,910
+529
+6% +$9.02K ﹤0.01% 829
2018
Q4
$110K Buy
8,381
+2,892
+53% +$38K ﹤0.01% 836
2018
Q3
$157K Buy
+5,489
New +$157K ﹤0.01% 797